Equivocal positives in standard in vitro assays can stall a genotoxicity testing program when there are no validated mechanistic follow-up before animal studies. Charles River Laboratories will offer Toxys’ ToxTracker® from its Den Bosch facility under license, following the Organisation for Economic Co-operation and Development (OECD) Test Guideline 446A.

Key Insights: The announcement does not state whether Den Bosch runs ToxTracker® under Good Laboratory Practice (GLP), a requirement for mutual acceptance of data alongside guideline conformance under the OECD GLP principles. Procurement leads may obtain written GLP scope before moving follow-up genotoxicity testing from the existing in vitro battery. 

Where Does ToxTracker® Fit When Choosing a Genotoxicity Partner?

ToxTracker fits as a mechanistic follow-up to equivocal or positive results from established in vitro assays, such as the Ames bacterial reverse mutation test. The ICH S2(R1) standard battery still governs human pharmaceuticals. The recent announcement does not claim that ToxTracker replaces any component.

The OECD Test Guideline 446A defines a stem cell-based assay in which six green fluorescent protein (GFP) reporters flag direct genotoxicity and stress responses, such as oxidative stress or protein damage.

Across four decision factors, the two assays differ in biology and output, which makes them complementary.

Decision FactorAmes TestToxTracker
Test systemBacterial strains of Salmonella typhimurium and Escherichia coliStem cell-based reporter assay
ReadoutRevertant colony countsGFP induction by flow cytometry
Information gainedPoint mutation detection. No direct data on mammalian mutagenic potency.Genotoxic and non-genotoxic mode-of-action signals. Cytotoxicity by relative cell count.
Role in genotoxicity testingInitial screen for genotoxic activity.Follow-up for equivocal or positive in vitro results.

Genotoxicity Testing Procurement Hinges on GLP Scope

GLP scope decides whether ToxTracker data from Den Bosch can support a regulatory submission. Charles River lists the site as GLP compliant since 1987. The announcement, however, left the new ToxTracker license’s GLP status open.

ReproTracker® is a human induced pluripotent stem cell-based assay that models aspects of early embryonic development to flag developmental toxicity hazards. Charles River offers it under a subcontracting agreement, with testing at Toxys. Sponsors can apply audit and quality-agreement steps to Toxys as the ReproTracker® testing subcontractor.

As more providers adopt the guideline, three confirmations before award protect a study’s regulatory usability and schedule:

  • GLP Status: Written confirmation that Den Bosch ToxTracker® studies run under GLP.
  • Turnaround: Report timing against the 2–3 weeks Toxys quotes for its own laboratory.
  • Sample Requirements: Compound quantities against Toxys’ 5–10 mg pharmaceutical and 50–100 mg chemical figures.

Allison Lintern, senior manager, business coordination for developmental and reproductive toxicology at Charles River Laboratories International, Inc., noted in a recent press release, “Our collaboration with Toxys gives clients earlier insight into potential genetic and developmental toxicity findings and supports more informed decisions before conducting in vivo studies.”

ToxTracker® Genotoxicity Testing: Next Steps

ToxTracker® adds a mechanistic follow-up to equivocal in vitro genotoxicity results, and the standard battery under ICH S2(R1) and the OECD Test Guidelines still anchors submissions. Charles River will offer ToxTracker® at Den Bosch under license and ReproTracker® through Toxys, with GLP scope unconfirmed. Sponsors should document guideline conformance, GLP status, turnaround, and subcontractor oversight before assigning study slots.

Sponsors outsourcing genotoxicity testing should verify GLP scope and mutual acceptance of data coverage for both assays against the EU GLP mutual acceptance rules. Connect with accredited toxicology and biocompatibility testing labs and pharmacology and drug development labs that can supply documented ToxTracker® and ReproTracker data packages with stated GLP scope.

Submit a free lab request to compare accredited labs on GLP scope and turnaround.

——–

The original press release can be found here.

This article was created with the assistance of Generative AI and has undergone editorial review before publishing.

Author

  • Sharon Dong, MSc, BSc (Hons), joined LabX Media Group (LMG) in 2026 as a Product News & Intelligence Editor. She has a strong background in cellular biology, microbiology, immunology, and molecular genetics. She is an experienced science education and outreach facilitator. Sharon is passionate about communicating science in ways that are clear, engaging, and accessible to a broad audience. In her free time, she enjoys solving jigsaw puzzles and cooking. Sharon can be reached at sdong@labx.com.

    View all posts